Advocacy

For Immediate Release: August 5, 2024, 11:30 a.m. U.S. Eastern Time Media Contact: Kara Flynn, (202) 257-8424, press@ashg.org American Society of Human Genetics (ASHG) President Bruce D. Gelb, M.D., released the following statement in response to the U.S. Senate Appropriations Committee’s approval by a 25-3 vote of the fiscal year (FY) 2025 bill for the... Read More

In May 2024, ASHG hosted a fourth year of virtual advocacy meetings with policymakers on Capitol Hill. Over the course of a week, participants in the  2024 cohort of the Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program joined members of past  ACGT  cohorts and members of the  Government and Public Advocacy Committee (GPAC)  in meetings with 15 congressional... Read More

In May 2023, ASHG hosted a third year of virtual advocacy meetings with policymakers on Capitol Hill. The week-long event brought together trainee advocates from both the 2022 and the 2023 Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program. Participation in this spring advocacy activity is a key feature of the ACGT program.... Read More

In May 2023, ASHG hosted its third year of virtual advocacy meetings on Capitol Hill. Both current and several former trainee advocates from the Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program participated in this week-long advocacy activity. The ACGT program was launched as part of ASHG’s Government & Public Advocacy Committee (GPAC)... Read More

The recently released White House Office of Science and Technology Policy (OSTP) report, Bold Goals for U.S. Biotechnology and Biomanufacturing, highlights where insights provided by human genetics and genomics are fundamental for the health biotechnology ecosystem and are critical components of the bioeconomy. This report comes after OSTP solicited public input in a Request for... Read More